Back to top
more

National Vision (EYE)

(Delayed Data from NSDQ)

$13.20 USD

13.20
1,140,149

-0.38 (-2.80%)

Updated Aug 2, 2024 04:00 PM ET

Pre-Market: $12.50 -0.70 (-5.30%) 8:24 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.03%
2Buy17.70%
3Hold9.37%
4Sell5.03%
5Strong Sell2.48%
S&P50011.19%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value A Growth D Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 40% (101 out of 251)

Industry: Medical - Products

Better trading starts here.

Zacks News

National Vision (EYE) Q2 Earnings Top Mark, Revenue View Cut

National Vision (EYE) is simultaneously facing demand headwinds across its network of stores, given the current macro environment, as well as supply challenges.

Company News for Aug 12, 2022

Companies in The News Are: HBI,DDS,SIX,EYE

National Vision (EYE) Q2 Earnings and Revenues Surpass Estimates

National Vision (EYE) delivered earnings and revenue surprises of 162.50% and 1.25%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

Why National Vision (EYE) Might Surprise This Earnings Season

National Vision (EYE) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Verano Holdings Corp. (VRNOF) Reports Next Week: Wall Street Expects Earnings Growth

Verano Holdings Corp. (VRNOF) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Is VAALCO (EGY) Poised for a Robust Q2 Earnings Performance?

While higher oil prices are likely to have boosted VAALCO Energy's (EGY) profit levels in the second quarter, escalation in costs might have played spoilsport.

National Vision (EYE) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

National Vision (EYE) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Can Higher Margins Boost HF Sinclair (DINO) Q2 Earnings?

While higher refining margins and throughput are likely to have boosted HF Sinclair's (DINO) profit levels in the second quarter, escalation in costs might have played spoilsport.

NanoString (NSTG) Surges 5.1%: Is This an Indication of Further Gains?

NanoString (NSTG) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

National Vision (EYE) Gains on Volume Growth Amid Margin Woes

National Vision (EYE) plans to continue executing its core growth initiatives and further investing in strengthening competitive advantages.

Here's Why You Should Retain National Vision (EYE) For Now

Investors are optimistic about National Vision's (EYE) better-than-expected earnings and new store growth.

National Vision (EYE) Up 21.6% Since Last Earnings Report: Can It Continue?

National Vision (EYE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

National Vision (EYE) Tops Q1 Earnings Estimates, Cuts '22 View

National Vision (EYE) reports better-than-expected earnings and an increase in store count for the first quarter.

National Vision (EYE) Q1 Earnings Top Estimates

National Vision (EYE) delivered earnings and revenue surprises of 22.22% and 4.07%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Owens & Minor (OMI) Beats Q1 Earnings and Revenue Estimates

Owens & Minor (OMI) delivered earnings and revenue surprises of 24.68% and 3.55%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

National Vision (EYE) Up 23.6% Since Last Earnings Report: Can It Continue?

National Vision (EYE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

National Vision (EYE) Hurt by Rising Costs, Vendor Dependency

High dependence on a limited number of suppliers exposes National Vision (EYE) to supplier concentration risk.

National Vision (EYE) Q4 Earnings Top Estimates, Margins Down

Strength in America's Best and Eyeglass World brands drove National Vision's (EYE) performance in the fourth quarter of 2021.

National Vision (EYE) Tops Q4 Earnings and Revenue Estimates

National Vision (EYE) delivered earnings and revenue surprises of 750% and 4.43%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Zynex Inc. (ZYXI) Q4 Earnings Surpass Estimates

Zynex Inc. (ZYXI) delivered earnings and revenue surprises of 21.05% and 1.69%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Analysts Estimate National Vision (EYE) to Report a Decline in Earnings: What to Look Out for

National Vision (EYE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Meridian Bioscience (VIVO) Q1 Earnings and Revenues Surpass Estimates

Meridian Bioscience (VIVO) delivered earnings and revenue surprises of 40% and 19.78%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Here's Why You Should Hold on to National Vision (EYE) for Now

Investors are optimistic about National Vision (EYE), given new store growth for America's Best and Eyeglass World brands.

Abbott (ABT) Scales to a 52-Week High: What's Driving It?

Strong performance by the Diabetes Care and Diagnostics businesses is driving the top line for Abbott (ABT).

Cardiovascular Systems (CSII) Business Down on COVID Resurgence

According to Cardiovascular Systems (CSII), the resurgence of COVID-19 and the related staffing shortages are disrupting referral patterns and having the largest impact on elective procedures.